carvedilol phosphate

The phosphate salt form of carvedilol, a racemic mixture and adrenergic blocking agent with antihypertensive activity and devoid of intrinsic… (More)
National Institutes of Health

Related topics

Related topics

19 relations
24 HR carvedilol phosphate 20 MG Extended Release Oral Capsule24 HR carvedilol phosphate 80 MG Extended Release Oral Capsule [Coreg]Angina PectorisArterial Vasodilation [PE]
(More)

Narrower (1)

Coreg

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
FORMULATION AND EVALUATION OF BUCCAL PATCHES OF CARVEDILOL PHOSPHATE
Carvedilol is a non-selective adrenergic antagonist with no intrinsic sympathomimetic activity widely used to treat essential… (More)
  • table 1
  • table 2
  • figure 1
  • table 3
  • table 4
Is this relevant?
2014
2014
Preparation and in vitro characterization of non-effervescent floating drug delivery system of poorly soluble drug, carvedilol phosphate.
The objective of the study was to enhance the solubility of carvedilol phosphate and to formulate it into non-effervescent… (More)
  • table I
  • table II
  • table III
  • figure 1
  • figure 2
Is this relevant?
2012
2012
Adherence and dosing frequency of common medications for cardiovascular patients.
OBJECTIVES To compare adherence between once-daily (QD) and twice-daily (BID) dosing with chronic-use prescription medications… (More)
Is this relevant?
2012
2012
In-vitro Release Study of Carvedilol Phosphate Matrix Tablets Prepared with Hydroxypropyl Methylcellulose
Purpose: To evaluate the effect of two molecular weight grades of hydroxypropyl methylcellulose on the release characteristics of… (More)
  • table 1
  • figure 2
  • figure 1
  • figure 3
  • table 2
Is this relevant?
2012
2012
SIMPLE SPECTROPHOTOMETRIC ESTIMATION OF CARVEDILOL PHOSPHATE IN BULK AND TABLET DOSAGE FORMS
A simple, sensitive and accurate UV spectrophotometric method has been developed for the determination of carvedilol phosphate in… (More)
  • table 2
  • figure 3
Is this relevant?
2011
2011
Formulation and characterization of an expandable, gastroretentive system of carvedilol phosphate by 32 factorial design.
UNLABELLED A 3(2) full factorial design was employed for the formulation and characterization of an expandable, gastroretentive… (More)
Is this relevant?
2011
2011
Novel design and synthesis of modified structure of carvedilol.
β-adrenergic blocking agents have been in use for nearly 40 years. β-blockers have been more thoroughly studied in the past… (More)
Is this relevant?
2010
2010
Development and in vitro evaluation of micronized sustained release matrix tablet of carvedilol
Carvedilol, a non selective β blocking drug under the biopharmaceutical classification system (BCS) class II, is widely used in… (More)
  • table 1
  • table 2
  • figure 1
  • table 3
  • figure 2
Is this relevant?
2009
2009
Assessment of solubilization characteristics of different surfactants for carvedilol phosphate as a function of pH.
The effect of surfactants on the solubility of a new phosphate salt of carvedilol was investigated at different biorelevent pH to… (More)
  • figure 2
  • figure 3
  • figure 1
  • figure 4
  • figure 6
Is this relevant?
2009
2009
Adherence with once daily versus twice daily carvedilol in patients with heart failure: the Compliance And Quality of Life Study Comparing Once-Daily Controlled-Release Carvedilol CR and Twice-Daily…
BACKGROUND Suboptimal compliance in taking guideline-based pharmacotherapy in patients with chronic heart failure (HF… (More)
Is this relevant?